Jeffrey Karp
Founder of Akita Biosciences
Boston, Massachusetts
Overview
Work Experience
Contributing Author
2024 - Current
Psychology Today is a publishing company that publishes news, articles, and magazines about wellness.
Co-Founder
2022
Akita Biosciences is a biotech organization pioneering novel intranasal therapies that help people live healthy and vibrant lives.
Author of LIT - Life Ignition Tools (Harper Collins - William Morrow Imprint)
2019
✨Please consider pre-ordering at your favorite retailer: http://bit.ly/3OUGWCO 🙏🏻 Life Ignition Tools are a set of holistic tools for living that emerged out of necessity from my own life. As a child struggling with undiagnosed ADHD and learning differences, I learned how to essentially take control of my brain’s neuroplasticity (neuroplasticity reflects our intrinsic link to nature - it's how our brain adapt and evolve in response to our environment and our thoughts, emotions, and actions) – it was a lifesaver! It gave me the ability to laser focus, enter the flow state on demand, improve memory, emotionally regulate, and more. Named LIT, these tools, inspired by nature and backed by science, empower anyone to lead a life rich in creativity, connection, and purpose. LIT got me through spectacular setbacks along the way (including being rejected from medical school, freezing during a TED talk, struggling to connect meaningfully with others, and countless other challenges) and to where I am today. And the thing is - anyone can do this and start living a life full of creativity, and connection and purpose. Additionally, "LIT" features insights from 40 interviewees, including Nobel laureates, Olympic medalists, social justice leaders, an indigenous leader, celebrated artists, and various scientists and inventors. They share their experiences disengaging from life on autopilot by activating the brain's inherent power to undergo transformative change.
HarperCollins is an English language publisher that offers a range of Bibles, atlases, dictionaries, and reissued classics.
Co-Founder
2019
Corner Therapeutics is a biotechnology research company that specializes in the immunotherapy paradigm.
Raised $54,000,000.00 from Sandia Holdings, Ziff Capital Partners and Tanis ventures.
Professor of Anesthesia
2007
Associate Professor
2012 - 2018
Co-Director of Regenerative Therapeutics
2010 - 2013
Assistant Professor
2009 - 2012
Instructor of Medicine
2007 - 2009
Co-Founder
2015
Editorial Advisory Board Member
2015
Honored to serve on the 2015,2016 and 2017 TEDMED Editorial Advisory Board for curating the stage program’s themes, topics, speakers and performers.
TEDMED is a global community that creates and shares stories in health and medicine that inform, inspire, engage, and provoke action.
Co-Founder, Scientific Advisory Board Member, and Board Observer
2016
Associate Member
2015
Co-Founder, Member of the Regenerative Medicine Advisory Board
2014
Frequency Therapeutics, is a biotechnology company at the forefront of translating ground breaking discoveries in the area of cell programming, an approach recognized with the 2012 Nobel Prize, to patients. Frequency has solved a key bottleneck in bringing stem cell programming to patients - namely by harnessing rapidly translatable small molecule combinations that selectively target stem cells in the body. The company is advancing a robust pipeline of small molecule combinations with novel mechanisms of action for hearing loss, gut diseases (including Crohn's disease and ulcerative colitis), diabetes, and ophthalmological diseases.